Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity
- 1 July 2017
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 135, 491-516
Abstract
No abstract availableKeywords
Funding Information
- The Slovenian Research and Innovation Agency (P1-0208)
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (OI 172044, TR 31060)
This publication has 70 references indexed in Scilit:
- Different inhibitory potency of febuxostat towards mammalian and bacterial xanthine oxidoreductases: insight from molecular dynamicsScientific Reports, 2012
- FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine OxidoreductaseThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Crystal Structures of Urate Bound Form of Xanthine Oxidoreductase: Substrate Orientation and Structure of the Key Reaction IntermediateJournal of the American Chemical Society, 2010
- Tautomerism in Cytosine and Uracil: A Theoretical and Experimental X-ray Absorption and Resonant Auger StudyThe Journal of Physical Chemistry A, 2010
- Insights into the inhibition of xanthine oxidase by curcuminBioorganic & Medicinal Chemistry Letters, 2009
- Mechanism of Inhibition of Xanthine Oxidoreductase by Allopurinol: Crystal Structure of Reduced Bovine Milk Xanthine Oxidoreductase Bound with OxipurinolNucleosides, Nucleotides & Nucleic Acids, 2008
- Studies on the mechanism of action of xanthine oxidaseJournal of Inorganic Biochemistry, 2004
- Role of P-Glycoprotein in PharmacokineticsClinical Pharmacokinetics, 2003
- Molecular modeling of flavonoids that inhibits xanthine oxidaseBiochemical and Biophysical Research Communications, 2002
- Synthesis and Biological Evaluation of New Imidazole, Pyrimidine, and Purine Derivatives and Analogs as Inhibitors of Xanthine OxidaseJournal of Medicinal Chemistry, 1996